Serveur d'exploration MERS - Exploration (Accueil)

Index « AbsEn.i » - entrée « design »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
desiccation < design < designability  Facettes :

List of bibliographic references indexed by design

Number of relevant bibliographic references: 315.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000007 (2020) Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine][Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)].
000071 (2020) Ning Wang [États-Unis] ; Jian Shang [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Lanying Du [États-Unis]Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
000072 (2020) Shan-Meng Lin [Taïwan] ; Shih-Chao Lin [États-Unis] ; Jia-Ning Hsu [Taïwan] ; Chung-Ke Chang [Taïwan] ; Ching-Ming Chien [Taïwan] ; Yong-Sheng Wang [Taïwan] ; Hung-Yi Wu [Taïwan] ; U-Ser Jeng [Taïwan] ; Kylene Kehn-Hall [États-Unis] ; Ming-Hon Hou [Taïwan]Structure-Based Stabilization of Non-native Protein–Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design
000077 (2020) Isabel Ortiz De Solorzano [Espagne] ; Karteek K. Bejagam ; Yaxin An ; Samrendra K. Singh ; Sanket A. DeshmukhSolvation dynamics of N-substituted acrylamide polymers and the importance for phase transition behavior.
000107 (2020) Syed Faraz Ahmed [République populaire de Chine] ; Ahmed A. Quadeer [République populaire de Chine] ; Matthew R. Mckay [République populaire de Chine]Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
000111 (2020) David A. Schwartz [États-Unis] ; Ashley L. GrahamPotential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections
000159 (2020) Tarun Bhatnagar [Inde] ; Manoj V. Murhekar [Inde] ; Manish Soneja [Inde] ; Nivedita Gupta [Inde] ; Sidhartha Giri [Inde] ; Naveet Wig [Inde] ; Raman Gangakhedkar [Inde]Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
000179 (2020) Mohsen Rokni [Iran] ; Vida Ghasemi [Iran] ; Zahra Tavakoli [Iran]Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
000195 (2020) Christopher Pockrandt [États-Unis] ; Mai Alzamel [Royaume-Uni] ; Costas S. Iliopoulos [Royaume-Uni] ; Knut Reinert [Allemagne]GenMap: Ultra-fast Computation of Genome Mappability.
000218 (2020) Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash MedhiDrug targets for corona virus: A systematic review
000227 (2020) Nashwa Hafez Zaher [Égypte] ; Mohammed Ismail Mostafa [Égypte] ; Abdullah Yousef AltaherDesign, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors.
000260 (2020) Entao Li ; Feihu Yan ; Pei Huang [République populaire de Chine] ; Hang Chi ; Shengnan Xu [République populaire de Chine] ; Guohua Li [République populaire de Chine] ; Chuanyu Liu [République populaire de Chine] ; Na Feng ; Hualei Wang [République populaire de Chine] ; Yongkun Zhao ; Songtao Yang ; Xianzhu Xia [République populaire de Chine]Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice
000286 (2020) Young-Seok Kim [Corée du Sud] ; Jongkwan Lim [Corée du Sud] ; Jemin Sung [Corée du Sud] ; Yucheol Cheong [Corée du Sud] ; Eun-Young Lee [Corée du Sud] ; Jihoon Kim [Corée du Sud] ; Hana Oh [Corée du Sud] ; Yeon-Sook Kim [Corée du Sud] ; Nam-Hyuk Cho [Corée du Sud] ; Seongil Choi [Suède] ; Sang-Moo Kang [États-Unis] ; Jae-Hwan Nam [Corée du Sud] ; Wonil Chae [Corée du Sud] ; Baik L. Seong [Corée du Sud]Built-in RNA-mediated Chaperone (Chaperna) for Antigen Folding Tailored to Immunized Hosts.
000297 (2020) Abdullah Sheikh [Arabie saoudite] ; Abdulla Al-Taher [Arabie saoudite] ; Mohammed Al-Nazawi [Arabie saoudite] ; Abdullah I. Al-Mubarak [Arabie saoudite] ; Mahmoud Kandeel [Arabie saoudite, Égypte]Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design
000303 (2020) Manoj Kumar Satheesan ; Kwok Wai Mui ; Ling Tim WongA numerical study of ventilation strategies for infection risk mitigation in general inpatient wards
000305 (2020) Shengjie Dong [République populaire de Chine] ; Jiachen Sun [République populaire de Chine] ; Zhuo Mao [République populaire de Chine] ; Lu Wang [République populaire de Chine] ; Yi-Lin Lu [République populaire de Chine] ; Jiesen Li [République populaire de Chine]A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV).
000327 (2019) Luis Martínez [Espagne] ; Martin Milani [Slovénie] ; Iker Malaina [Espagne] ; Carmen Álvarez [Espagne] ; Martín-Blas Pérez [Espagne] ; Ildefonso M. De La Fuente [Espagne]Weighted lambda superstrings applied to vaccine design
000366 (2019) Robert N. Kirchdoerfer ; Andrew B. WardStructure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
000372 (2019) Will Pm Rowe [Royaume-Uni] ; Anna Paola Carrieri [Royaume-Uni] ; Cristina Alcon-Giner [Royaume-Uni] ; Shabhonam Caim [Royaume-Uni] ; Alex Shaw [Royaume-Uni] ; Kathleen Sim [Royaume-Uni] ; J. Simon Kroll [Royaume-Uni] ; Lindsay J. Hall [Royaume-Uni] ; Edward O. Pyzer-Knapp [Royaume-Uni] ; Martyn D. Winn [Royaume-Uni]Streaming histogram sketching for rapid microbiome analytics
000404 (2019) Elena V. Petrova [États-Unis] ; Vasanthi Avadhanula [États-Unis] ; Sarah Michel [États-Unis] ; Karen E. Gincoo [États-Unis] ; Pedro A. Piedra [États-Unis] ; Sharmila Anandasabapathy [États-Unis]Remote Laboratory Management: Respiratory Virus Diagnostics.
000408 (2019) Olujide O. Olubiyi [Nigeria] ; Maryam O. Olagunju ; Birgit Strodel [Allemagne]Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "design" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "design" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    design
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021